Workvivo by Zoom is named preferred migration partner for Workplace from Meta

Meta is discontinuing Workplace and will partner with Workvivo to assist with customer transitions.

SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) — Today, Workvivo by Zoom was named Meta’s only preferred migration partner for its customers as it retires Workplace from Meta.

Meta is discontinuing Workplace from Meta – its employee engagement platform. To assist with customer transitions, Meta will partner with Workvivo as its only preferred migration partner.

Workplace from Meta and Workvivo plan to provide migration tools for customers migrating to Workvivo and Workvivo will also offer additional implementation services at no further cost to support customers’ transition.

Workplace from Meta customers can find more information about migrating to Workvivo here.

John Goulding, CEO and founder of Workvivo, said: “We know that the news today may be disruptive for Workplace from Meta customers, but we’re so excited about the opportunity to support and help them. Meta has made a huge impact in this market, and we believe that Workvivo is the natural choice for Workplace from Meta customers to transition their employee experience platform.

“It’s our top priority to support customers through this transition, and our team is working to make this process as frictionless as possible. We put our customers first, and this will be no different for the Workplace from Meta customers. We are excited to welcome Workplace from Meta customers into our incredible customer community and see the amazing things they can do with Workvivo.”

Eric S. Yuan, CEO and founder of Zoom said: “Since Workvivo joined the Zoom family, we’ve seen how powerful this platform is at engaging workforces and bringing culture to life – especially for frontline employees who may not have a desk or even an email address. Workvivo has seen momentous growth as organizations around the world are increasingly prioritizing the employee experience. We are excited to support Workplace from Meta’s customers and help them reach their goals of reaching and engaging employees – whether they’re desk or frontline workers.”

Workvivo by Zoom is the employee experience platform that simplifies communication and increases engagement by empowering employees to be heard and helping everyone feel included, no matter where they work.

Acquired by Zoom in 2023, Workvivo extends the Zoom Workplace platform to offer its customers new ways to keep employees informed, engaged, and connected. Workvivo is working with some of the world’s best-known brands to help them boost employee engagement and bring their culture to life digitally, including Dollar General, the Virgin Group, Bupa, Ryanair, Lululemon and Amazon.

About Workvivo by Zoom

Workvivo is an employee experience platform that simplifies communication and increases engagement by empowering employees to be heard and helping everyone feel included, no matter where they work. The platform unifies employee communications, engagement, intranet, and measurement features into one modern employee app that captures the heartbeat of the organization and brings its culture to life.

Founded in 2017, Workvivo has seen momentous growth, which led to its acquisition by Zoom in 2023. Workvivo powers the employee experience at companies all over the world across all industries, including Amazon, Motherson, White Castle, Bupa and Ryanair. Workvivo regularly tops software review sites, including Gartner Digital, with a #1 spot on G2 for internal communications, intranet and engagement tool categories. For more information, visit

Public Relations
Eleanor O’Mahony

GlobeNewswire Distribution ID 9117415

MedSource Labs Announces Innovation in Safety, Accuracy and Functionality of IV Catheters

MedSource Labs Unveils ClearSafe Comfort® and TrueSafe Comfort® Blood Control Safety IV Catheters to protect medical staff and patients

[Minneapolis, Minnesota, Chanhassen], May 14, 2024 (GLOBE NEWSWIRE) — MedSource Labs moves the needle in the peripheral safety IV market with the announcement of ClearSafe Comfort and TrueSafe Comfort Blood Control IV Catheters with groundbreaking active blood control check valve technology.

ClearSafe Comfort and TrueSafe Comfort Blood Control IV catheters provide significant benefits over other IV catheters.

  1. Safety: A new blood control device to significantly reduce the risk of exposure to bloodborne pathogens to the caregiver and patient.
  2. Precision: A translucent flashback chamber confirms vessel entry and ensures accuracy.
  3. Front-line functionality: The ergonomic design and non-slip grip ensure easy handling for healthcare workers.


“Healthcare professionals subject themselves to the risks associated with needlestick injuries and exposure to bloodborne pathogens every time they access a vein,” said Dave Kunelius, President at MedSource Labs. “ClearSafe Comfort and TrueSafe Comfort Blood Control Safety IV Catheters have been engineered to minimize these risks, allowing medical staff to better serve their patients without distraction or worry.”

These devices conform to the U.S. Needlestick Safety and Prevention Act.

MedSource Labs is a leading medical product developer and supplier specializing in high-quality products and innovative medical product development. The ClearSafe Comfort and TrueSafe Comfort Blood Control Safety IV Catheters are part of MedSource Labs’ high-performing IV catheter lines focused on caring for the caregiver. See the TrueSafe Animations and ClearSafe Animations for a detailed view.

“Quality has always been a key component of our IV catheter products, and the ClearSafe Comfort and TrueSafe Comfort blood control products raise the bar for medical staff safety and patient care,” said Kunelius.

MedSource Labs is ISO 13485:2016 certified for quality management in medical device manufacturing, registered with the FDA, and the blood control catheters are 510(k) Cleared Products.


MedSource Labs is a leading provider of quality medical products, specializing in high-quality products, equipment and innovative class II medical product development. For over two decades, MedSource Labs has been a trusted provider of quality medical products at a superb value. Recently, MedSource Labs has expanded into new markets and grown its international services and offerings, including a focus on the EMERGE product imagine/design/build process.


Jeremy Belloit
MedSource Labs
(952) 472-0131

GlobeNewswire Distribution ID 9116905

Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024

Mont-Saint-Guibert, Belgium – May 13, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the first quarter 2024 on Tuesday, May 14, 2024, after market close. Company management will host a conference call to discuss financial results that day beginning at 10:30pm CET / 4:30pm ET.

A webcast of the call will be accessible via the Investor Relations page of the Nyxoah website or through this link: Nyxoah’s Q1 2024 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Nyxoah’s Q1 2024 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.

The archived webcast will be available for replay shortly after the close of the call.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

For more information, please visit

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Forward-looking statements
Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; and the Company’s results of operations, financial condition, liquidity, performance, prospects, growth and strategies. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2023, filed with the Securities and Exchange Commission (“SEC”) on March 20, 2024, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

David DeMartino, Chief Strategy Officer


GlobeNewswire Distribution ID 1000950583

UET Lahore Hosts Inaugural Pak Polymer Symposium, Bridging Industry and Academia

Lahore, The Department of Polymer and Process Engineering at the University of Engineering and Technology (UET) Lahore successfully hosted the 1st Pak Polymer Symposium 2024. The event, held at the Chemical Engineering Seminar Hall, brought together industry leaders and academic professionals to discuss innovations and challenges in polymer engineering.

According to University of Engineering and Technology, the symposium was sponsored by the Pakistan Science Foundation, Pak Petrochemicals Ltd., and chaired by Prof. Dr. Asif Ali Qaiser. The chief guest, Mr. Kashif Anwar, President of the Lahore Chamber of Commerce and Industries, emphasized the importance of strong connections between academia and industry and praised the department’s efforts in establishing these linkages.

The highlight of the event was a plenary speech by Prof. Dr. John Verbeek from the University of Auckland, New Zealand, who discussed a transdisciplinary approach to addressing New Zealand’s plastic waste problem. The symposium also featured five technical sessions focusing on various aspects of polymer engineering, including product design, injection molding, extrusion industry, recycling challenges in packaging, advanced polymer composites, and new materials for elastomers.

The event attracted delegates from notable industry names such as SPEL, FlexPac Association, RON Extrusion, and Panther Tires, among others. Additionally, the symposium included a poster competition where COMSATS University Islamabad secured the first position, followed by ITPE, Punjab University in second place.

The symposium concluded with the distribution of shields and certificates to the organizers and volunteer students, marking a significant step towards enhancing industry-academic collaboration in the field of polymer engineering.

University of the Punjab to Host Seminar on Environmental Impacts of CPEC

Lahore, The Centre for South Asian Studies at the University of the Punjab is set to host an international seminar on the environmental and societal impacts of the China-Pakistan Economic Corridor (CPEC). The event, featuring guest speakers from Estonia and Poland, is scheduled for May 15, 2024, at 2:00 p.m.

According to University of the Punjab, the seminar titled “CPEC’s Environmental Toll: Implications on the Society” will include presentations by Dr. Agnieszka Niza Makowska from the University of Tartu, Estonia, and Dr. Kerry Longhurst from the Institute of Politics and International Relations at Collegium Civitas, Poland. The seminar aims to discuss and analyze the broader environmental and social repercussions associated with the ongoing development projects under CPEC.

The event is open to scholars, students, and professionals interested in the environmental challenges posed by large-scale infrastructure projects like CPEC. It seeks to provide a platform for critical analysis and dialogue on how these projects impact societal structures and ecological balances.

IIUI’s Shariah Academy Conducts Islamic Law Orientation Course in Islamabad

Islamabad, The Shariah Academy of the International Islamic University Islamabad (IIUI) successfully conducted a two-day Islamic Procedural Law Orientation Course, drawing participation from approximately 50 senior law officers, lawyers, law graduates, and law students from both Pakistan and abroad. The course aimed to enhance understanding and application of Islamic legal principles within the context of modern law practice.

According to International Islamic University Islamabad, the training included in-depth discussions on various critical aspects of Islamic law such as Means of Proof in Islamic and Pakistan Law, the Role of Precedents and Lawyers in the Islamic Judicial System, Modes of Investigation, and the Role of Women as Qazi (judge) and Witness. The event featured a series of lectures delivered by esteemed scholars and practitioners in the field of Islamic law.

Prominent speakers such as Prof. Dr. Ata Ullah Faizi, Director-General of the Shariah Academy, and Barrister Usama Malik, Director of the Directorate of Legal Education at the Pakistan Bar Council, shared their expertise. They were joined by other notable experts including Prof. Dr. Anwarullah, former advisor to the Sultan of Brunei, and Dr. Moti ur Rehman from the Federal Shariat Court, who contributed to the rich discourse on the applicability of Islamic jurisprudence in contemporary legal frameworks.

The course concluded with a ceremony at the Faisal Majid Campus of the university, where participants expressed their appreciation for the opportunity to deepen their understanding of Islamic legal principles. Prof. Dr. Ata Ullah Faizi thanked the university’s administration, particularly IIUI Rector Prof. Dr. Samina Malik and President Prof. Dr. Hathal Hamoud Alotaibi, for their support in making the event possible. He also acknowledged the efforts of the Shariah Academy’s faculty and staff in organizing the course.

This event underscores IIUI’s commitment to fostering a deeper understanding of Islamic jurisprudence among future legal professionals and enhancing its application in legal practices worldwide.